As you can see my conclusions were correct that their cash burn has increased to over 20 million per quarter, standing currently at least 23 million per quarter. This figure will probably continue to show increases going forwards.
Thus the 144 million they raised earlier will last them 1 year and about an extra quarter before they will need to raise again. And at what will probably average at a 25 million per quarter burn, expect heavy heavy raises afoot for a long while. Remember their most advanced candidate is in Phase I trials, many many years away from potential commercialisation.
The newly published 10q states they have a total of 183 million as of March 31st 2019, so giving them about another 40 million of emergency cash, but to which they will probably raise before going into those funds.
I hope you are now reading into company cash burns more deeply and will avoid calling others negligent.
good luck!
Recent FATE News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:02:49 PM
- Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates • GlobeNewswire Inc. • 05/09/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 01:01:04 PM
- Fate Therapeutics Announces First Lupus Patient Treated in Phase 1 Autoimmunity Study of Off-the-shelf FT819 CAR T-cell Program • GlobeNewswire Inc. • 05/09/2024 12:30:00 PM
- Fate Therapeutics to Webcast Conference Call Reporting First Quarter 2024 Financial Results and Operational Updates • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting • GlobeNewswire Inc. • 05/03/2024 08:30:00 PM
- Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting • GlobeNewswire Inc. • 04/22/2024 08:30:00 PM
- Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/02/2024 08:01:00 PM
- Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement • GlobeNewswire Inc. • 03/19/2024 12:44:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:24:31 PM
- Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/05/2024 09:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 06:29:13 PM
- Fate Therapeutics to Present at Upcoming March Investor Conferences • GlobeNewswire Inc. • 03/01/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2024 09:10:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 09:03:08 PM
- Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates • GlobeNewswire Inc. • 02/26/2024 09:01:00 PM
- Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/12/2024 11:06:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:10:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:10:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:09:29 PM
- Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/02/2024 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:01:19 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM